show episodes
 
Artwork

1
PAULCAST

Paul Arun

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
Welcome to "Business Chronicles", the podcast where we explore the fascinating stories behind some of the world's most iconic companies and places. A journey through the rich histories and intriguing tales of businesses and locations that have shaped our world.
  continue reading
 
Formerly known as the Holmes Report‘s Echo Chamber, the PRovoke podcast brings insight and intelligence from the global PR industry. Featuring interviews, analysis and conversation, the weekly show is hosted by PRovoke Media editors Arun Sudhaman, Maja Pawinska Sims & Paul Holmes.
  continue reading
 
Artwork
 
Exploring the practical and exciting alternate realities that can be unleashed through cloud driven transformation and cloud native living and working. Each episode, our hosts Dave, Esmee & Rob talk to Cloud leaders and practitioners to understand how previously untapped business value can be released, how to deal with the challenges and risks that come with bold ventures and how does human experience factor into all of this? They cover Intelligent Industry, Customer Experience, Sustainabili ...
  continue reading
 
This Life Science focused podcast brings together Xtalks editorial staff to share insights into the latest B2B industry news. Xtalks connects professionals in the life science, medical device, and food industries with useful content like webinars, job opening, articles and virtual meetings.
  continue reading
 
Loading …
show series
 
I sat down with Benjamin Jolley, a third-generation pharmacist who recently addressed a crowd of 20,000 about the broken world of PBMs. We dug into the power of that moment, the hidden mechanics of pharmacy monopolies, and what real reform could look like. This one hits where policy meets reality.
  continue reading
 
Traditional businesses are transforming to enhance consumer engagement and operational efficiency by integrating advanced technologies, helping them stay competitive in the digital age; how can technology best support this transformation? This week, Dave, Esmee and Rob talk to Sandeep Seeripat, CIO at Twinings about how the 300-year-old tea company…
  continue reading
 
Biotech CEO Arun Swaminathan reveals how true pharmaceutical deals are strategic “marriages”—not transactions. Hear how Coya Therapeutics leverages partnerships, builds trust, and aims to transform ALS care. A candid look at negotiation, leadership, and why win-win deals matter in pharma and beyond. Real insights from the C-suite.…
  continue reading
 
[AAA] In 'Access All Areas' shows we go behind the scenes with the crew and their friends as they dive into complex challenges that organisations face—sometimes getting a little messy along the way. This week, in what may or may not be our 100th episode, Dave, Esmee and Rob talk to James Wilson, AI Ethicist and Lead Gen AI Architect and Philip Hark…
  continue reading
 
In this episode, Ayesha speaks with Ebrahim S. Delpassand, MD, Founder and CEO of RadioMedix, a company developing innovative radiopharmaceuticals for cancer diagnosis, monitoring and treatment. With a focus on both PET imaging and therapeutic radiopharmaceuticals labeled with alpha and beta emitters, RadioMedix is helping to shape the future of pr…
  continue reading
 
Can a small biotech change cancer care—and turn a profit? Paul Romness, CEO of OS Therapies, shares how his five-person team took on one of the deadliest pediatric cancers, went public, and might just shake up the system. From biologics to Wall Street, this one’s got it all. Sponsored by Dae Lee of Buchanan.…
  continue reading
 
Understanding the true environmental cost of digital innovation is crucial for governments aiming to embed sustainability into their digital delivery processes. Governments are embedding sustainability into the heart of digital delivery. Can governments ensure that their digital advancements contribute positively to the environment while maintainin…
  continue reading
 
In this episode, Ayesha speaks with Norman Putzki, MD, Senior Vice President and Global Development Head of Neuroscience and Gene Therapy at Novartis, about the complexities and real-world challenges of bringing new therapies to patients with neurological diseases. Dr. Putzki discusses the challenges and opportunities in developing treatments for c…
  continue reading
 
Marco Benitez, founder of ROOK, reveals how his company turns chaotic wearable data into clean, actionable insights. From fitness rings to Dexcom integrations, hear how ROOK bridges tech and healthcare, enabling remote monitoring, AI-driven predictions, and more—all without the red tape of FDA regulation. The future of health is wearable. Sponsored…
  continue reading
 
At Knowledge 2025, the spotlight is on big announcements and bold innovations—but we’re taking you behind the scene!. In this two-part special, we dive into the engine driving ServiceNow’s evolution, with exclusive conversations you won’t hear on the main stage. In Part 2, Dave, Esmee, and Rob speak with Amanda Joslin, Senior Director of Platform a…
  continue reading
 
At Knowledge 2025, the spotlight is on big announcements and bold innovations—but we’re taking you behind the scene!. In this two-part special, we dive into the engine driving ServiceNow’s evolution, with exclusive conversations you won’t hear on the main stage. In Part 1, Dave, Esmee, and Rob sit down with Karel van der Poel, SVP of Products at Se…
  continue reading
 
In this episode, Ayesha speaks with Sumita Bhatta, MD, Vice President and Global Development Therapeutic Head of Rare Disease at Amgen. In the conversation, Dr. Bhatta shares insights on how large pharmaceutical companies like Amgen are approaching innovation and patient-centricity in the rare disease space. She also discusses the unique challenges…
  continue reading
 
I sat down with Autumn Kyoko Cushman, co-founder of ShiftRx, staffing leader, to hear how she and her team clawed their way back from the edge. From bounced credit cards to nationwide scale—this one’s raw, real, and a must-listen for anyone building in pharmacy.
  continue reading
 
TechnoVision 2025 by Capgemini helps business leaders and technologists understand and prioritize emerging technologies. It provides a clear view of tech trends, guiding decision-makers to enhance organizational effectiveness. TechnoVision acts as a beacon in the evolving technology landscape. In this very special episode, Dave, Esmee, and Rob talk…
  continue reading
 
In this episode, Ayesha spoke with Paul Romness, MHP, chair and CEO of OS Therapies, a company developing novel immunotherapies for cancers like osteosarcoma and other solid tumors. Paul shares insights into OS Therapies’ lead program, the scientific rationale behind the company’s innovative immunotherapy approach and how the company is addressing …
  continue reading
 
Golin chief AI officer Jeff Beringer joins the PRovoke Media podcast to discuss his vision for being a fully AI-integrated PR agency. If all goes as planned, Golin by 2026 will be the first fully AI-integrated PR firm, transforming everything from workflow and jobs to the nature of client relationships. In this episode of the PRovoke Media podcast,…
  continue reading
 
The host and his brothers (Mike Koelzer, along with brothers Pete Koelzer⁠, ⁠Tom Koelzer⁠, ⁠and Tim Koelzer⁠) return to where it all started—the family drugstore. From early paper routes to late nights after close mopping the store, they reflect on the work ethic, values, and business lessons they learned from their dad. It’s a heartfelt, behind-th…
  continue reading
 
In this episode of the Hype Pod, Arun and Adam Smallcombe welcome Jeremy Maranitch, tech sales leader and former fitness coach turned Snowflake partnerships expert. Jeremy’s unconventional journey from personal training in Texas to working alongside Silicon Valley’s top founders is filled with hustle, wisdom, and insight into what it takes to thriv…
  continue reading
 
In this episode, Ayesha spoke with Dr. Shaharyar Khan, co-founder and chief scientific officer at Rivus Pharmaceuticals. Rivus is developing a new class of investigational medicines called controlled metabolic accelerators (CMAs) for cardiometabolic diseases like diabetes, heart disease, heart failure and MASH by targeting obesity. Dr. Khan is an e…
  continue reading
 
I sat down again with Kris Rhea to unpack how pharmacies are silently losing money—just by buying wrong. We talk wholesaler games, misunderstood contracts, and the AI tool trying to fix it all. If you’ve ever felt like your drug spend makes no sense, this one’s for you.
  continue reading
 
This year is the year that AI moves from the individual assistant to the collective and autonomous - from co-pilots to agent to agent integration. But what do we know of its collective impact and how does humanity fit in? This week’s Easter Special, Dave, Esmee and Rob talk to Anders Indset, about his work (Ex Machina and the Singularity Paradox), …
  continue reading
 
In this episode of The Hype Pod, join host Arun and Pastor Adam as they delve into the dynamic world of real estate with special guest Juan Ruan, President of Kinetic Real Estate. Discover how faith intersects with innovation and hear Juan's inspiring journey from a Chinese immigrant growing up in Mexico to becoming a successful real estate entrepr…
  continue reading
 
In this episode, Ayesha spoke with Marc Hedrick, MD, MBA, president and CEO of Plus Therapeutics, a company focused on developing a novel class of targeted radiotherapeutics. Prior to heading Plus Therapeutics, Dr. Hedrick served in a number of executive leadership roles including president, CEO and director at Cytori Therapeutics, and president an…
  continue reading
 
I sat down with Joey Dizenhouse, CEO of SlateRx, to talk about redefining pharmacy benefits—minus the gimmicks. We dug into transparency, real fiduciary alignment, and how SlateRx is tackling PBM dysfunction head-on. If you're tired of smoke and mirrors in the benefits space, this episode is for you. Sponsored by WaypointRx.…
  continue reading
 
Hello Las Vegas — we’ve arrived for Google Cloud Next 2025! Arthur C. Clarke's third law, "Any sufficiently advanced technology is indistinguishable from magic" Hot drop coming through! The #CloudRealities podcast team has landed in electric Las Vegas—and you know what they say: what happens in Vegas normally stays in Vegas... but in this case, we’…
  continue reading
 
Hello Las Vegas — we’ve arrived for Google Cloud Next 2025! Arthur C. Clarke's third law, "Any sufficiently advanced technology is indistinguishable from magic" Hot drop coming through! The #CloudRealities podcast team has landed in electric Las Vegas—and you know what they say: what happens in Vegas normally stays in Vegas... but in this case, we’…
  continue reading
 
This year has already seen rapid and significant disruption in the media, policy and business landscape. Meanwhile, the increasing sophistication of disruptive technologies are leading to further confusion. Finn Partners partner David Krejci – a pioneer in media forensics, and an expert on misinformation, disruptive technologies, and bad faith acto…
  continue reading
 
Hello Las Vegas — we’ve arrived for Google Cloud Next 2025! Hot drop coming through! The #CloudRealities podcast team has landed in electric Las Vegas—and you know what they say: what happens in Vegas normally stays in Vegas... but in this case, we’re bringing 8 incredible conversations in the coming days with inspiring guests who are shaping the f…
  continue reading
 
Hello Las Vegas — we’ve arrived for Google Cloud Next 2025! Arthur C. Clarke's third law, "Any sufficiently advanced technology is indistinguishable from magic" Hot drop coming through! The #CloudRealities podcast team has landed in electric Las Vegas—and you know what they say: what happens in Vegas normally stays in Vegas... but in this case, we’…
  continue reading
 
Hello Las Vegas — we’ve arrived for Google Cloud Next 2025! Arthur C. Clarke's third law, "Any sufficiently advanced technology is indistinguishable from magic" Hot drop coming through! The #CloudRealities podcast team has landed in electric Las Vegas—and you know what they say: what happens in Vegas normally stays in Vegas... but in this case, we’…
  continue reading
 
Hello Las Vegas — we’ve arrived for Google Cloud Next 2025! Arthur C. Clarke's third law, "Any sufficiently advanced technology is indistinguishable from magic" Hot drop coming through! The #CloudRealities podcast team has landed in electric Las Vegas—and you know what they say: what happens in Vegas normally stays in Vegas... but in this case, we’…
  continue reading
 
Hello Las Vegas — we’ve arrived for Google Cloud Next 2025! Arthur C. Clarke's third law, "Any sufficiently advanced technology is indistinguishable from magic" Hot drop coming through! The Cloud Realities podcast team has landed in electric Las Vegas—and you know what they say: what happens in Vegas normally stays in Vegas... but in this case, we’…
  continue reading
 
Hello Las Vegas — we’ve arrived for Google Cloud Next 2025! Arthur C. Clarke's third law, "Any sufficiently advanced technology is indistinguishable from magic" Hot drop coming through! The #CloudRealities podcast team has landed in electric Las Vegas—and you know what they say: what happens in Vegas normally stays in Vegas... but in this case, we’…
  continue reading
 
In this episode, Ayesha spoke with Carlos Martin, MBA, chief commercial operations and revenue officer at Rocket Pharmaceuticals, a company developing gene therapy cures for rare diseases through innovative science and platforms. Carlos joined Rocket in April 2021 and established the company’s early commercial strategy and infrastructure as Chief C…
  continue reading
 
I sat down with attorneys Dae Lee and Adam Farkas to dig into the legal mess surrounding GLP-1 compounding, PBM overreach, and the brutal reality facing independent pharmacies. Dae’s a pharmacist-attorney, Adam’s a legal powerhouse, and together they’re helping pharmacies fight back in a system stacked against them.…
  continue reading
 
As organizations increasingly integrate Gen AI into their operations, it's crucial to consider the technology's environmental impact. However, only 12% of executives report that their organizations measure Gen AI's footprint, and just 20% prioritize its environmental footprint among the top five factors when choosing or developing models. Despite t…
  continue reading
 
In this milestone 50th episode of the Hype Podcast, hosts Arun and Vance are joined by special guest Anto Patrex, founder and CEO of CosmicBrain AI. Anto shares his incredible journey from big tech AI to leading his own AI startup. The discussion delves into the exciting advancements in AI and quantum computing, covering topics such as robotics, th…
  continue reading
 
In this episode, Ayesha spoke with Marshall Fordyce, MD, founder and CEO of Vera Therapeutics, a company focused on developing treatments for autoimmune diseases. Dr. Fordyce founded Vera in 2016 as an entrepreneur in residence at Kleiner Perkins Caufield and Byers, took the company public in 2021 and has advanced its lead molecule through a succes…
  continue reading
 
Michelle Woosley blends pharmacy know-how with M&A savvy. She shares how independent pharmacy owners can build value, avoid costly mistakes, and attract serious buyers—including private equity. Thinking about selling your pharmacy someday? Don’t miss this one. Michelle’s advice could mean the difference between walking away… or leaving money on the…
  continue reading
 
AI and Generative AI are transforming cybersecurity by enhancing threat detection and response. These technologies offer unmatched accuracy and efficiency, making them crucial for protecting sensitive data. As cyber threats evolve, integrating AI into security strategies is essential. This week, Dave, Esmee and Rob talk to Corence Klop, CISO at the…
  continue reading
 
In this episode, Ayesha spoke with Shalabh Gupta, MD, founder, chairman and CEO of Unicycive Therapeutics, a company focused on addressing unmet medical needs in renal diseases. Kidney diseases are a major global health concern. In the US, chronic kidney disease (CKD) affects more than one in seven individuals, and one in three adults with diabetes…
  continue reading
 
What makes a pharmacy—or a pharmacy vendor—stand out? Nicolle McClure and Bruce Kneeland join me to unpack real-world marketing strategies, pitfalls, and how pharmacies can avoid bland messaging. We dig into trust, niche focus, and why “friendly service” isn’t enough anymore. Straight talk, no fluff—just actionable insights.…
  continue reading
 
The telecom industry is undergoing a fundamental transformation. This shift is creating new business opportunities and services but also brings significant challenges in transformation and modernization. In a new five-part mini-series, Reimagining Telecoms, we will explore these challenges through five distinct lenses: Growth, Networks, Simplificat…
  continue reading
 
Join us as we celebrate a major milestone — the 200th episode of the Xtalks Life Science Podcast! From groundbreaking biotech innovations to exclusive interviews with life science industry innovators and leaders, we've covered it all. Thank you for tuning in each week! We look forward to continuing to bring the latest and greatest across the pharma…
  continue reading
 
In Episode 49, the hosts discuss their recent experiences, focusing on travel, restructuring, and scaling systems for future growth. They delve into an audacious vision for Vibe Church—aiming for 100 locations in 10 years—reflecting on the ambitious yet necessary nature of the goal. The conversation shifts to the state of the US economy, discussing…
  continue reading
 
Discover how cutting-edge pharmacy technology and digital healthcare are transforming patient care. In this episode, Rick Ratliff, CEO of MedAdvisor Solutions, dives into the latest innovations shaping the industry. From medication adherence to digital health solutions, this conversation is a must-listen for those navigating the evolving pharmacy l…
  continue reading
 
In the complex technology landscape, getting the people right is crucial for success. When the right team is in place, the technology will naturally follow, leading to impactful outcomes. Building a strong team ensures that the organization can navigate challenges and leverage technological advancements effectively. This week, Dave, Esmee and Rob t…
  continue reading
 
In this episode, Vera spoke with Ann Beliën, PhD, founder and CEO of Rejuvenate Biomed, a biotech company leveraging AI-driven platforms to develop therapies for age-related diseases and promote healthy aging. Rejuvenate Biomed is aiming to transform the treatment landscape for diseases such as sarcopenia, neuromuscular, metabolic and neurodegenera…
  continue reading
 
Loading …

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play